Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trends In Diagnostics 2011

24 Jan 2012

Related Content

Fast As A Whip, Pfizer Files Personalized Lung Cancer Drug Crizotinib

12 Jan 2011

The How And When Of Applying Sequencing To Clinical Diagnostics

01 Sep 2010

Is Diagnostics the New Biotech...and Will Pharma Embrace It?

01 Sep 2011

Genomics Through The Lens Of Precompetitive Data Sharing

23 Jan 2012

Molecular Dx Reimbursement: Medicare Contractor Seeks Tighter Controls

17 Oct 2011

With Genoptix, Novartis Continues Its Diagnostics Build-up

01 Feb 2011

Personalized Medicine In 2010: Welcome To The Establishment

01 Jan 2011

What's Fueling The Recent Diagnostics Dealmaking?

01 Apr 2011

Related Companies

Pacific Biosciences of California, Inc.

Complete Genomics Inc.

Illumina, Inc.

Life Technologies Corporation

US Department of Health and Human Services

National Institutes of Health

Affymetrix, Inc.

Thermo Fisher Scientific

Novartis AG

NeoGenomics, Inc.

General Electric

General Electric

Nestle Health Science

Nestle Health Science

Prometheus Laboratories Inc.

Procter & Gamble

Pfizer Inc.

Roche Holding AG

Genentech, Inc.

Abbott

bioMerieux SA

bioMerieux SA

Johnson & Johnson

Additional Topics

Business Strategies Deals Medical Device

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.